Cardio Intelligence, an AI Medical Device Company, Secures Series B Funding to Accelerate Overseas Expansion

Funding Rounds

▤ Summary

Cardio Intelligence has closed the first tranche of its Series B round through a third-party allotment. Shin Nippon Biomedical Laboratories led the round, with Tokai Tokyo Investment and Iwagin Business Creation Capital also participating. The company will use the money to improve products, strengthen its organization, and expand overseas. Its AI-based medical device software already has regulatory traction and market adoption, and the new funding should speed up quality improvements and international rollout.

$ Funding

$
Amount - Total raised
□
Date November 20, 2025 Announcement date
◎
Investors PR Times, Shin Nippon Biomedical Laboratories Lead investors
▥
Company https://www.cardio-i.com/ Funded company

▥ Classifications

industries
HealthTech
applications
Content Management

◇ AskAI Classifications

Labels
Healthcare Software Medical Devices Software AI/ML Software

▦ Linked Companies